Additional file 2 of Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape
2020-06-01T03:21:16Z (GMT) by
Additional file 2. Pattern and distribution of the TP53 mutations in the cohort according to (A) Mutation type (B) Mutation effect on TP53 protein sequence (C) Exon/ Intron distribution (D) Functional effect (E) SIFT prediction (IARC TP53 Database). (N = 100, lung cancer subjects).